掲示板のコメントはすべて投稿者の個人的な判断を表すものであり、
当社が投資の勧誘を目的としているものではありません。
-
-
握力は…人それぞれですからね(笑)
良きIR貼り🤗
-
かなり遅れて@5.50で入りました。早速赤ですが、握ってりゃいいんだよね？
-
3でinでももう益益🤗ですね！♪
まだまだまだまだ行って欲しいです↗️ -
14バガー(笑)
こうなるとほぼ利益にしか見えない🤗
ダヴィンチと同じような等読むとまだ(まだ)持っていていいかなと握力…✊
-
-
やはり日本も参戦してるのね
本日のガイア
ヒノトリ -
TransEnterix is eyeing this rapidly expanding greenfield opportunity, which can become even bigger in the post-pandemic world. As risks of COVID-19 infection mount, robotic surgery can help limit human interaction and offer increased safety both for the surgeon and the patient. There is also limited competition to Senhance from other specialized robotic systems in the laparoscopic surgery space.
Although the COVID-19 pandemic has affected case volumes of Senhance-assisted laparoscopic procedures in 2020, the volumes are set to improve in 2021. TransEnterix has received FDA clearance and CE Mark approval for its Intelligent Surgical Unit (ISU), a machine vision system used in conjunction with Senhance. The CE approval allows the use of the Senhance System in Europe. The ISU technology adds artificial intelligence and robotic vision capabilities to the Senhance system, reducing the laparoscopic surgeon's learning curve and the potential for human mistakes. The company is also uniquely positioned to capture a significant chunk of the pediatric laparoscopic procedure market, thanks to having smaller instrumentation as compared to other robotic surgery players.
TransEnterix has also managed to maintain a debt-free balance sheet. The company's pro-forma cash on Jan. 14 was $84.1 million, which includes proceeds from registered direct offering, warrant exercises, and share sales. TransEnterix has projected its cash runway to last until the end of 2022.
There are also many regulatory catalysts anticipated in the first half of 2020 that can further push up share prices. TransEnterix is expecting the FDA's clearance for use of the Senhance system in general surgery indication. The company also plans to file applications seeking FDA approval for its next-generation ISU technology and articulating instruments.
Senhance良さそうな文が多い
米finance板も強気な発言増えてきた
がんばれtrxc🤗 -
3から入るということは10くらい見てるのかしら🤗
-
成りセット完了
明日インします。
タイミングも良さそうだし。 -
こんな板あったんですね！！
私はかなり遅れてはいったので2＄位です。
豊島病院は残念ながらコロナ専門病院に
なってしまいましたね。 -
こんばんは～🤗
まさかご訪問頂けるとは(笑)
そうですね、私は日本の豊島の時に記事に当たれて入りました😊 -
昨日一瞬テンバガー❗🤗🤗🤗
去年からの持ち越しだけど１銘柄１月にテンバガーは素直に嬉しい🎶🤗🎶
がんばれtrxc🤖
-
-
invにも米financeにもハッキリ出る
さすがにもう目立った🤗笑
４(約５)バガー超えをプレで見る事に…とりあえず喜んでおこう♪🎶
-
-
-
trxc無い？ので作りました😊
最近やっと動き始めたのでさらに↗️となりますように🤗
-
ace-
恐妻組合
きゅンたん
shi*****
読み込みエラーが発生しました
再読み込み
○バガーを目指して🤗